AN2 Therapeutics, Inc.
ANTX
Rank in Stocks
#16538
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical... AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease. This enterprise was established in 2017 and operates from its headquarters situated in Menlo Park, California.
Share Price
$4.46
Last synced: 2026-11-11
Market Cap
$205.67M
Change (1 day)
3.00%
Change (1 year)
277.97%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade AN2 Therapeutics, Inc. (ANTX)
Category
Healthcare
EPS for AN2 Therapeutics, Inc. (ANTX)
EPS as of June 2026 TTM: $-1.07
According to AN2 Therapeutics, Inc.'s latest financial reports, its current EPS (TTM) is $-1.07. At the end of 2025 the company had an EPS of $-1.16, an increase over its 2024 EPS of $-1.72.
EPS history for AN2 Therapeutics, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.07 | -7.76% |
| 2025 | $-1.16 | -32.56% |
| 2024 | $-1.72 | -37.23% |
| 2023 | $-2.74 | -1.79% |
| 2022 | $-2.79 | 86.00% |
| 2021 | $-1.50 | 92.31% |
| 2020 | $-0.78 | 160.00% |
| 2019 | $-0.30 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,563.55% |
US
|
|
| $-7.07 | 560.75% |
US
|
|
| $-5.29 | 394.39% |
AU
|
|
| $12.88 | -1,303.75% |
BE
|
|
| $21.56 | -2,114.95% |
NL
|
Questions about AN2 Therapeutics, Inc.'s earnings per share (EPS)
What is AN2 Therapeutics, Inc.'s earnings per share (EPS)?
AN2 Therapeutics, Inc.'s earnings per share (EPS) over the last twelve months is $-1.07, as of Jun 2026.
What was AN2 Therapeutics, Inc.'s earnings per share (EPS) in 2025?
In 2025, AN2 Therapeutics, Inc.'s earnings per share (EPS) was $-1.16, compared with $-1.72 in 2024.
How has AN2 Therapeutics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, AN2 Therapeutics, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.78) and lowest in 2022 ($-2.79).
How does AN2 Therapeutics, Inc.'s earnings per share (EPS) compare with similar companies?
AN2 Therapeutics, Inc.'s earnings per share (EPS) ($-1.07) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.